Ozempic maker sues US rival over ad campaign

Summary

Novo Nordisk has claimed that Eli Lilly is using bad data to compare the companies' weight-loss and diabetes products in its ads.

Lotu Radar provides attributed news summaries and links to the original publisher. Full reporting and copyright remain with the source.